|
Search
Collections
Benchmarks
Upload document
Organization
Crystal and Structural Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 poster
Poster
Zenocutuzumab, an antibody that can overcome HER3 mediated NRG1 signaling in tumor cells by docking on HER2
